Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151.3 USD | -0.89% |
|
+0.75% | +56.97% |
Jun. 26 | Monetary policy is getting even more confusing | ![]() |
Jun. 26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.97% | 14.43B | |
+20.32% | 127B | |
+24.15% | 117B | |
+25.44% | 27.67B | |
-18.48% | 20.33B | |
-15.17% | 16.79B | |
-16.30% | 15.63B | |
+12.78% | 14.84B | |
-47.10% | 14.65B | |
+149.53% | 12.49B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Sarepta Therapeutics, Inc. Enters into License Agreement with Nationwide Children’S Hospital for Galgt2 Gene Therapy Program